REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 12, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") announced today that it received transparency noti...Read More
PRESS RELEASEREGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 11, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of the Belgian Law of May 2, 2007 regarding t...Read More
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Eurotin Inc. (“Eurotin” or the “Company”) (TSXV:TIN) and Lions Bay Capital Inc. (“Lions Bay”) (TSXV:LBI) are pleased to announce that the Company and certain debtholders, including Lions Bay, have entered into...Read More
REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 3, 2018, 22:00h CEST - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification pursuan...Read More
Toronto, Ontario--(Newsfile Corp. - December 22, 2017) - Eurotin Inc. ("Eurotin" or the "Company") (TSXV: TIN) is pleased to announce that the Company has completed a private placement of 19,047,619 common shares in the capital of the Company ("Shares") for gross proceeds of $1,000,000 at a price of...Read More
PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform Leuven (BELGIUM) - December 20, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG) ("TiGenix" or "the Company"), an advanced biopharmaceutic...Read More
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease &#x...Read More
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae New York, USA, Melbourne, Australia and Leuven, Belgium, December 15, 2017, 0...Read More
TSX.V: TIGOTCMKTS: TIGCFFrankfurt: 8N61 VANCOUVER, Dec. 11, 2017 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce that its trading symbol on the OTCQB Venture Market has changed to TIGCF effective December 7,...Read More
TSX.V: TIGOTCMKTS: TIGCFFrankfurt: 8N61 VANCOUVER, Dec. 11, 2017 /PRNewswire/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce that its trading symbol on the OTCQB Venture Market has changed to TIGCF effective Decem...Read More
TORONTO, ON--(Marketwired - December 08, 2017) - Toachi Mining Inc. ("Toachi" or the "Company") (TSX VENTURE: TIM) is pleased to announce the appointment of Mr. Joseph Fazzini, CPA, CA, CFA as the Company's Chief Financial Officer ("CFO") effective December 5,...Read More
Leuven (Belgium) - November 24, 2017, 22:00h CEST -TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of major holdings in issuers whose securities a...Read More
TORONTO, ON--(Marketwired - November 24, 2017) - Toachi Mining Inc. ("Toachi" or the "Company") (TSX VENTURE: TIM) announces that the Board of Directors of the Company has approved the grant, subject to receipt of the approval of the TSX Venture Exchange, to Nicholas Tintor o...Read More
Toronto, Ontario--(Newsfile Corp. - November 24, 2017) - Eurotin Inc. (TSXV: TIN) ("Eurotin" or the "Company"), is pleased to announce that it has filed its second quarter unaudited condensed interim consolidated financial statements and related management's discussion and analysis for the three and...Read More
TSX.V: TIGOTCMKTS: NFRGFFrankfurt: 8N61 VANCOUVER, Nov. 20, 2017 /PRNewswire/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) ("Triumph Gold" or the "Company") is pleased to announce that recent soil sampling has defined a 1.8 X 0.75 km multi-element (Au, Cu, Pb, Zn, As,...Read More
PRESS RELEASE TiGenix to present positive 52-week Phase III Cx601 data at EHA-SWG Scientific Meeting Leuven (BELGIUM) - November 20, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties o...Read More
TSX.V:TIGOTCMKTS: NFRGFFrankfurt: 8N61 VANCOUVER, Nov. 15, 2017 /PRNewswire/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) ("Triumph Gold" or the "Company") is pleased to announce that exploration drilling in an underexplored portion of the Revenue soil anomaly intersected high-grade gol...Read More
PRESS RELEASE TiGenix announces approval of trade name for lead development candidate Cx601 in Europe International Nonproprietary Name (INN), darvadstrocel, approved for Cx601 Leuven (BELGIUM) - November 16, 2017, 7h:00 CET - TiGenix NV (Euronext Brussels and...Read More
PRESS RELEASE TiGenix announces partial conversion of bondsLeuven (BELGIUM) - November 6, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells t...Read More
TSX.V: TIGOTCMKTS: NFRGF Frankfurt: 8N61 VANCOUVER, Nov. 2, 2017 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) ("Triumph Gold" or the "Company") is pleased to announce that prospecting and step out drilling to the east and west of the Revenue diatreme have been rewarded with signifi...Read More